Viral skin infections are commonly present in organ transplant recipients (OTR). In this study, we aimed to identify factors associated with human papillomavirus (HPV) infections in OTR. Patients with solid-organ transplants were recruited from the outpatient nephrology and dermatology clinics in five European countries. Only patients with no current or past skin cancer were included in this analysis. Serum samples were analysed for antibodies to the L1 proteins of 26 cutaneous and two genital HPV types from five phylogenetic genera (a, b, c, m and n). The most consistent association was found between recreational sun exposure and the seroprevalence of all tested genera, except a. The antibody presence of any b type was higher among people who had been transplanted at least 23 years prior to participation than in those who had been transplanted for less than 7 years. The prevalence of two c-HPV types (60 and 65) and three b-HPV types (15, 38 and 49) was associated with time since transplantation. The presence of a high number of warts was associated with the presence of any m-PV or n-PV types, and having greater than 50 keratotic skin lesions was almost significantly associated with the presence of antibodies to two or more c-PV. Discrepancies in the results of the present study, as well as in previous reports, may depend on different methodologies and on geographical variations. Our results also indicate that further research with more standardized methods is needed to clarify the role of cutaneous HPV in OTR.
INTRODUCTION
Organ transplant recipients (OTR) are prone to developing a variety of skin lesions. Immunosuppressive drugs used to reduce the risk of graft rejection facilitate infections and diminish immunosurveillance of UV-damaged cells. Skin of OTR is commonly infected with viruses (Tan & Goh, 2006) . Important aetiological agents include the human herpesviruses, the human papillomaviruses (HPV), polyomaviruses and molluscum contagiosum virus. In this study, we focused on HPV.
Papillomaviruses (PV) are a group of small, epitheliotropic, circular dsDNA viruses, which can infect cutaneous or mucosal epithelia. Of 189 PV types that have been characterized and classified so far (Bernard et al., 2010) , more than 120 infect humans. HPV are grouped into the taxonomic levels of family, genus, species, type, subtype and variant (de Villiers et al., 2004) Cutaneotropic HPV are phylogenetically heterogeneous and can be classified into wart-associated types (genera c, m, n, and species 2 and 4 of genus a) and epidermodysplasia verruciformis (EV)-associated types (genus b). HPV are present in normal skin of immunocompetent people (Astori et al., 1998) and they are one of the most frequent infections in immunosuppressed OTR (Bouwes Bavinck & Berkhout, 1997) .
HPV in general are increasingly recognized as important human carcinogens (Bouvard et al., 2009) . So far, their aetiological role in cutaneous malignancy is not confirmed, however it has been shown that cutaneous human b-PV types are associated with the development of cutaneous squamous cell carcinoma in patients with the inherited disorder EV (Orth, 2004) . Moreover an association between b HPV seroprevalence and squamous cell carcinoma has been found in immunocompetent people (Karagas et al., 2010; Masini et al., 2003) . DNA of human b-PV has been detected in squamous cell carcinoma lesions both from immunosuppressed OTR and immunocompetent patients (Berkhout et al., 2000; Harwood et al., 2000; Mackintosh et al., 2009) . Systemic or UV-induced immunosuppression, hyperproliferation of the epithelium (psoriasis) and/or the specific genetic background of the host (e.g. EV) may lead to increased virus production (Pfister, 2003) . Thus, it is important to identify risk factors for HPV infections in both immunocompetent and immunosuppressed persons.
In this study, we aimed to identify factors associated with HPV infection in OTR with no history of skin cancer. We investigated the association between the seroprevalence of 28 cutaneous and genital HPV types and factors, such as gender, age, skin phototype, hair colour, sun exposure, smoking, alcohol consumption, type of transplantation, time after transplantation, presence of keratotic skin lesions and warts.
RESULTS
We recruited 542 OTR without skin cancer, 128 of whom came from the United Kingdom (UK), 108 from The Netherlands, 156 from Germany, 53 from France and 97 from Italy. Only patients with complete serological data were included in this analysis. The main characteristics of the study population are summarized in Table 1 . Patients from France were older than the others, and for France and Italy the percentages of men were higher than for the other countries. As expected, the olive skin phototype was more frequent in France and Italy compared with the UK, The Netherlands and Germany. The reported number of hours of sun exposure was greater for France and Italy, and the reported number of painful sunburns before the age of 20 years was particularly high for France and The Netherlands. France and the UK were the countries with a higher percentage of alcohol consumers, and in Germany there were only 20 % smokers. The most frequent type of transplant was a renal allograft. The majority of transplantations had occurred more than 5 years before the study, except for Germany where 30.9 % of transplants had occurred 5 or less years before. Keratotic skin lesions were frequently observed in The Netherlands and in the UK, and warts in the UK.
The seroprevalence of 28 analysed HPV types is graphically represented in Fig. 1(a, b) . The most frequent types (more than 20 %) in all countries examined were HPV1, 63, 6, 4, 65, 8, 15, 17, 38 and 49 . The most frequent type in the UK was HPV1, in The Netherlands HPV6, in Germany HPV6 and 4, and in France and in Italy HPV8. The prevalence of HPV1 was significantly higher in the UK than in the other countries, HPV48 was lower in France, and HPV8 was higher in Italy. Even though it was not to a significant level, several HPV b types were more frequent in Italy than in the other countries, and the difference was significant compared with France for types HPV24, 17 and 92.
Among patients with at least one HPV a type, the mean number of a types patients were seropositive for was 1.15 in France, 1.25 in the UK, 1.29 in Italy, 1.37 in The Netherlands and 1.39 in Germany. The mean number of c-PV types patients were seropositive for was 1.65 in France, 1.96 in Italy, 2.02 in Germany, 2.05 in the UK and 2.09 in The Netherlands. The mean number of b-PV types patients were seropositive for was 3.61 in France, 4.07 in The Netherlands, 4.19 in the UK, 4.79 in Germany and 4.98 in Italy.
The associations between risk factors and HPV genera are shown in Table 2 . Significant associations were observed between sun exposure of .4 h day 21 of recreational sun exposure and the prevalence of any m-PV or n-PV, any c-PV and any HPV b-PV type. Having more than 50 warts was associated with the presence of any m-PV or n-PV. The presence of more than 50 keratotic skin lesions was associated with having antibodies to two or more c-PV types, although this was of borderline statistical significance. An inverse association was observed between age and the presence of any mucosal a HPV type.
The prevalence of some HPV types according to time after transplantation was analysed. Only the HPV types with a prevalence significantly different (P,0.1) between the first time period (2-7 years after transplantation) and the last one (¢23 years) are shown in Fig. 2(a, b) . A significant increase in the prevalence of positivity was observed for two HPV c types (60 and 65) and for three HPV b types (15, 38 and 49) . The association with time from transplantation also remained significant for these HPV types after simultaneously controlling for gender, age, skin phototype, sunburns and sun exposure during the weekend in a multiple logistic regression model. The other HPV types did not show an association with time after transplantation, and no type showed an inverse association (data not shown).
In the multivariate analyses (Table 3) , '¢4 h of recreational sun exposure per week' was significantly associated with the presence of any m or n type, any c type, and any b HPV type. The prevalence of any mucosal a HPV type was lower in people aged over 60 years than in those younger than 60, and people aged from 50 to 60 years had the highest prevalence of antibodies to m or n types. The presence of any b type HPV was associated with time after transplantation of 23 years or more, and from 8 to 12 years. The association between warts and any m or n HPV type also remained significant in the multivariate analysis (Table 4) . 
DISCUSSION
There is increasing interest in the natural history of skin HPV types, especially since several studies suggest their possible association with cutaneous squamous cell carcinoma (Asgari et al., 2008; Bouwes Bavinck et al., 2010; Feltkamp et al., 2008; Karagas et al., 2010; Proby et al., 2011) . We have recently reported the factors associated with the seroprevalence of 26 HPV types, with a particular focus on exposure to UV radiation, in a group of immunocompetent people ; the main findings were that men had higher prevalence of antibodies to b and c HPVs than women, and recreational sun exposure was associated with b-PV seropositivity, although this was only in Australia. In the current study we investigated whether similar associations were observed in OTR. We chose to study only OTR with no history of skin cancer in order to identify the risk factors independently from the presence of skin cancer.
The first observation from our study in OTR was that there were considerable differences in the seroprevalence of the individual HPV types in different countries. In particular, the seroprevalence of several b-PV types was significantly greater in Italy than in the other countries, and was particularly low in France. This increased seroprevalence of b-PV in Italy was also found in the study from immunocompetent patients in Italy, The Netherlands and Australia , and large differences in the prevalence of each HPV type were found in the different countries. However, such observations may simply reflect differences between study centres rather than differences between countries. In fact, in a study conducted with OTR in the UK (Casabonne et al., 2009), significant differences in individual HPV seroprevalence were also found between centres in the same country.
Concerning risk factors, the most consistent association in OTR was found between recreational sun exposure and HPV seroprevalence (except for a HPV types). The association was independent of the country and other sun-related variables, as shown in the multivariate analysis. In the previous study concerning immunocompetent patients , this association was found only with b-PV seropositivity, and only in Australia. In the present study in OTR, the other variables related to sun exposure, such as eye colour, skin phototype, number of sunburns and even sun exposure during the week, were not associated with HPV seropositivity for any type. In the study in OTR by Casabonne et al. (2009) , an association between sunbathing and seropositivity to multiple c-PV types was reported, and in a previous study (Termorshuizen et al., 2004) sunburn episodes in the past, especially at 13-20 years of age, appeared to be associated with an enhanced risk of EV-HPV DNA positivity.
We found no association between gender and HPV seropositivity, in contrast to findings previously reported in immunocompetent people, among whom men had a higher seroprevalence of cutaneous HPV types both in people with (Karagas et al., 2006; Waterboer et al., 2008) and without ) squamous cell carcinoma. Contrary to the findings for immunocompetent people ), we did not observe a consistent effect of age on HPV seroprevalence, except for an inverse association between age and the presence of any mucosal a HPV type, and a higher seroprevalence among the 50-60 year olds for m/n HPV types in OTR.
Another result of interest in the present study was the significant association between time after transplantation and the presence of the b-PV types 15, 38 and 49. These viruses have already been reported as having significant transforming potential in vitro. A study by Massimi et al. (2008) showed that HPV 15 and 49, among others, have significant transforming potential. It has also been shown that E6 and E7 of HPV38 have transforming activity in primary human cells, thus suggesting a role for HPV38 infection in skin carcinogenesis (Caldeira et al., 2003; Viarisio et al., 2011) . Also, HPV38 alters p53 functions (Accardi et al., 2006) , and expression of HPV38 E6 and E7 in mouse skin also promotes p53 and DNp73 accumulation (Dong et al., 2008) . Time after transplantation has been identified as an important risk factor for actinic keratoses and skin cancer in OTR (Bouwes Bavinck et al., 2007) . Also, in a previous study concerning the presence of b-PV DNA in OTR , the only significant association was found with time after transplantation.
The association between the number of warts and the presence of any m-PV or n-PV type confirms previous observations (de . A high number of keratotic skin lesions was associated with the presence of two or more HPV c types. In previous studies, b HPV has F. Sampogna and others been detected in actinic keratoses and other keratotic skin lesions both in OTR (Berkhout et al., 2000; Harwood et al., 2000) and in immunocompetent people (McBride et al., 2007; Plasmeijer et al., 2009) , but c HPV types have not been extensively studied. However, it has to be considered that warts and keratotic skin lesions may be the results of HPV infection, which is different from the association with the other factors.
Comparing the seroprevalence of HPV types in OTR and in immunocompetent people , no significant differences were found (data not shown), with A strength of our study is that all the sera were analysed for HPV in the same laboratory and by using a well validated technique (Karagas et al., 2006; Waterboer et al., 2005) . A limitation of our study is that the distribution of risk factors in the different countries was not uniform. This could reflect real differences, but may also depend on a different selection of patients or a different interpretation of questions. Moreover, it was not possible to perform an accurate analysis on the effect of each immunosuppressive drug, since over a period of time patients are generally treated with a number of different drugs in different doses and the immune-modulating medication was diverse between the centres in the five countries. Possibly, because of the large variation in immune-modulating medication, we did not observe an association of immune-modulating medication with HPV serology. However, it has been shown that the risk of cutaneous squamous cell carcinoma in OTR recipients was related to the cumulative immunosuppressive drug dose 3 years after transplantation rather than to one specific drug (Fortina et al., 2004) . It is plausible that the same concept applies here, so, rather than analysing each drug independently, it may be more appropriate to investigate the cumulative immunosuppression, as represented by the time since transplantation.
In conclusion, the analysis of HPV seroprevalence in OTR with no history of skin cancer showed that the seroprevalence of HPV types was different in five European countries. The seroprevalence of all HPV types, except of both cutaneous and mucosal a-PV, was associated with recreational sun exposure, and time after transplantation was associated with b-PV types 15, 38 and 49. Differences in the data obtained in the present study compared with previous studies may reflect either improved serological methodologies, different data collection or different populations, and thus indicate that further work with more standardized methods, at least in all three of the major disciplines involved in this research (virology, dermatology and epidemiology), is needed to clarify the role of cutaneous HPV in OTR.
METHODS
This study is part of an EC-grant-funded multicentre case-control study investigating the association of HPV infections, sun exposure and other factors with the development of squamous cell carcinoma and/or basal cell carcinoma. Data were collected both from immunocompetent people and OTR. Data about HPV serology in the immunocompetent population are described elsewhere , and information about the prevalence and risk factors for the detection of HPV in both immunosuppressed and immunocompetent participants has been described by de Koning et al. (2009 Types of transplants were grouped into 'renal' and 'other', which included heart transplants and the combinations kidney-pancreas, kidney-liver and kidney-heart. Patients with only liver, lungs and pancreas transplants were not included in the study.
We categorized skin type into 'olive' and 'medium/fair', based on questions about tanning ability, sun reactivity and self-reported skin colour (Bouwes Bavinck et al., 2007) . The number of hours of work and recreational sun exposure were grouped into low (1-3 h day 21 ) and high (¢4 h day 21 ) exposure. Cigarette pack-years were calculated from the number of cigarettes per day divided by 20, multiplied by the duration (years) of smoking. Grams of alcohol were determined with the help of a list of drinks with their respective amounts of alcohol, and patients were grouped as follows: no consumption, low consumption (1-19 g day 21 ) and high consumption (¢20 g day 21 ).
Keratotic skin lesions included actinic keratoses, seborrhoeic warts, flat warts and hyperkeratotic papillomas. We counted verrucae vulgaris and verrucae plantares separately. Diagnoses were made on clinical grounds since it is not feasible to obtain histological diagnoses for all lesions. Patients with (Fitzpatrick) skin types V and VI were not included in the study (Bouwes Bavinck et al., 2007) .
Serum samples from study participants were analysed for antibodies to the L1 proteins of the cutaneous HPV types 2 and 3 (species A2 and A4 of the a genus), 5, 8, 20, 24, 36, 9, 15, 17, 23, 49, 75, 4, 48, 50, 60, 65, , 1, 63 (m-PV) and 41 (n-PV), as well as the mucosal HPV types 6 and 16 (a-PV). In addition, the VP1 proteins of the human polyomaviruses BK and JC were included as internal-control antigens. We used multiplex serology to detect antibodies, as previously described (Waterboer et al., 2005) . Glutathione S-transferase (GST)-L1-tag fusion proteins from cleared bacterial lysates were affinity-purified in situ through binding to glutathione casein-coated fluorescencelabelled polystyrene beads. Each fusion protein was bound to a spectrally distinct bead set. Fusion protein-loaded bead sets were mixed. Sera were pre-incubated at 1 : 50 dilution in PBS (pH 7.4) containing 1 mg ml 21 casein, 2 mg ml 21 lysate from bacteria expressing GST tag alone, to block antibodies directed against residual bacterial proteins and GST tag, as well as 0.5 % polyvinyl alcohol, 0.8 % polyvinylpyrrolidone and 2.5 % Superchemiblock (Millipore) to suppress non-specific binding of antibodies to the beads (Waterboer et al., 2006) . Serum dilutions were incubated with the same volume of mixed bead sets, resulting in a final serum dilution of 1 : 100. Bound antibodies were detected with biotinylated goat anti-human IgG (H+L) secondary antibody and streptavidin-Rphycoerythrin. A Luminex analyser (xMAP; Luminex) was used to identify the internal colour of the individual beads and to quantify their reporter fluorescence [expressed as median fluorescence intensity (MFI) of at least 100 beads per set per serum]. A fusion protein consisting of GST and tag without intervening viral antigen served for determination of the background signal. Study sera were analysed once on each of three consecutive days. A quality control panel (QC) of 46 sera was included in each experiment, resulting in three QC datasets to determine inter-day variation. Cut-off values to define seropositivity for all antigens were set to an MFI of 200, as defined previously .
Univariate analyses were performed in order to investigate the association between the prevalence of antibodies to each HPV and the following variables: country, gender, age (,50, 50-59.9 and ¢60 years), skin phototype, number of painful sunburns before 20 years of age, sun exposure during the week and the weekend, smoking, alcohol consumption, transplant type (renal versus other), years after transplantation, number of keratotic skin lesions and number of warts. The prevalence of each HPV type was calculated at different times after transplantation, categorized as in a previous study (2-7 years, 8-12, 13-17, 18-22 and 23 or more years; de Koning et al., 2009) . We then grouped participants according to seropositivity into groups of HPVs as follows: one or more m or n types, one or more cutaneous a type, one or more mucosal a type, one c type, two or more c types, one to three b types and four or more b types. We used the x 2 test to assess the significance of the associations; P,0.05 was considered statistically significant.
A series of logistic regression models were then performed, by using antibody positivity as a dependent variable, and the variables that were significant in the univariate analysis or that could be considered as potential confounders as independent variables.
